A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent

Published 2018 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 10, Issue 442, Pages eaah4807
Publisher
American Association for the Advancement of Science (AAAS)
Online
2018-05-24
DOI
10.1126/scitranslmed.aah4807

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.